...More clinical trial results for 2 vaccines that aim to be more durable & "variant-proof", including the one from GeoVax that's also being tested in people on cancer treatment.
The other is the self-amplifying mRNA vax from Arcturus that's authorized in Japan. Signs of immune response didn't wane as much as Pfizer's did by 6 months.
In other news, clinical trial data on a mucosal vaccine, & 2 more pancoronavirus vaccines are going into phase 1 trial in France.
2/2